J&J On Product Reformulation: Consumer Demand Plays A Role
This article was originally published in The Rose Sheet
Executive Summary
In an interview with “The Rose Sheet,” Johnson & Johnson’s Susan Nettesheim, vice president of toxicology and product stewardship, discussed the firm’s recent decision to reformulate its personal-care products without or with reduced levels of formaldehyde, phthalates, triclosan and other ingredients.
You may also be interested in...
J&J Slapped With Another Talc Cancer Verdict As More Claimants Line Up
J&J is ordered to pay $55m in damages to a woman who attributes her ovarian cancer to prolonged perineal use of the company's talc-based powders. The decision comes less than three months after a $72m finding against J&J in a similar case tried in the same St. Louis court, but this one may bode more ominously for the firm's prospects in a long line of related cases to come, plaintiff's counsel suggests.
J&J Consumer Business Picks Up, But Analysts See Long Road
J&J’s consumer business inched up 1% operationally in Q3, including about 6% growth at constant currency in OTC/nutritionals. However, costs associated with the remediation of McNeil OTC facilities are expected to weigh on J&J through most of 2013.
J&J To Remove Formaldehyde, Other Concerns From Personal-Care Items
In response to consumer demand, J&J will remove controversial ingredients from both baby and adult brands, including Neutrogena, Aveeno, Lubriderm and Clean & Clear.